AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 170 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $7,178,000 | +1588.9% | 151,117 | +907.4% | 2.65% | +904.5% |
| Q4 2018 | $425,000 | -92.8% | 15,000 | -88.0% | 0.26% | -90.6% |
| Q3 2018 | $5,908,000 | +492.0% | 125,179 | +747.0% | 2.81% | +633.2% |
| Q2 2018 | $998,000 | +24.4% | 14,779 | 0.0% | 0.38% | +22.4% |
| Q1 2018 | $802,000 | -9.2% | 14,779 | 0.0% | 0.31% | +0.6% |
| Q4 2017 | $883,000 | +23.0% | 14,779 | 0.0% | 0.31% | +11.5% |
| Q3 2017 | $718,000 | -85.4% | 14,779 | -84.2% | 0.28% | -85.1% |
| Q2 2017 | $4,926,000 | +624.4% | 93,822 | +525.5% | 1.87% | +620.0% |
| Q1 2017 | $680,000 | -86.9% | 15,000 | -89.1% | 0.26% | -88.9% |
| Q4 2016 | $5,210,000 | – | 138,000 | – | 2.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,464,749 | $98,944,000 | 34.86% |
| Foresite Capital Management III, LLC | 1,708,046 | $115,379,000 | 24.85% |
| Eversept Partners, LP | 226,902 | $15,327,230 | 7.01% |
| SECTORAL ASSET MANAGEMENT INC | 615,870 | $41,602,000 | 4.65% |
| DAFNA Capital Management LLC | 131,770 | $8,901,000 | 4.17% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 68,666 | $4,638,000 | 3.67% |
| Asymmetry Capital Management, L.P. | 49,756 | $3,361,000 | 3.30% |
| PFM Health Sciences, LP | 2,720,218 | $183,751,000 | 2.88% |
| HealthCor Management, L.P. | 1,314,290 | $88,780,000 | 2.82% |
| Boulegeris Investments, Inc. | 66,540 | $4,495,000 | 2.25% |